Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months

ClinicalTrials.gov ID: NCT02163499

Public ClinicalTrials.gov record NCT02163499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Multi-Dose, Open-Label Maintenance of Long-Term Safety and Efficacy of Sodium Zirconium Cyclosilicate (ZS) in Hyperkalemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Open-Label Maintenance Study contains an Acute Phase, in which subjects will be dosed with ZS 10 g three times daily (tid) for 24 to 72 hours, followed by a long-term Maintenance Phase.

Study identification

NCT ID
NCT02163499
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ZS Pharma, Inc.
Industry
Enrollment
751 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2014 (Actual)
Primary completion
Nov 30, 2016 (Actual)
Completion
Nov 30, 2016 (Actual)
Last update posted
Jun 27, 2018

2014 – 2016

United States locations

U.S. sites
36
U.S. states
17
U.S. cities
34
Facility City State ZIP Site status
Not listed Scottsboro Alabama 35768 —
Not listed Tempe Arizona 85284 —
Not listed Tucson Arizona 85724 —
Not listed Chula Vista California 90717 —
Not listed Los Angeles California 90022 —
Not listed Paramount California 90723 —
Not listed Riverside California 92505 —
Not listed Sacramento California 95825 —
Not listed Whittier California 90603 —
Not listed Denver Colorado 80230 —
Not listed Brandon Florida 33511 —
Not listed DeLand Florida 32720 —
Not listed Hudson Florida 34667 —
Not listed Lauderdale Lakes Florida 33313 —
Not listed Miami Florida 33015 —
Not listed Miami Florida 33125 —
Not listed Miami Lakes Florida 33018 —
Not listed New Smyrna Beach Florida 32168 —
Not listed Tampa Florida 33614 —
Not listed Winter Park Florida 32789 —
Not listed Columbus Georgia 31901 —
Not listed Evergreen Park Illinois 60805 —
Not listed Joliet Illinois 60435 —
Not listed Paducah Kentucky 42003 —
Not listed Shreveport Louisiana 71101 —
Not listed Chesterfield Michigan 48047 —
Not listed Kansas City Missouri 64411 —
Not listed St Louis Missouri 63110 —
Not listed Great Neck New York 11021 —
Not listed Providence Rhode Island 02903 —
Not listed Orangeburg South Carolina 29118 —
Not listed Sumter South Carolina 29150 —
Not listed Chattanooga Tennessee 37408 —
Not listed San Antonio Texas 78215 —
Not listed San Antonio Texas 78229 —
Not listed St. George Utah 84770 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02163499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2018 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02163499 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →